SPRC
SciSparc Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$5.29
+3.12%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.2M | 856.0K | 1.3M | 2.9M | 1.3M |
| Cost of Revenue | 1.3M | 225.0K | 800.0K | 683.0K | 322.0K |
| Gross Profit | 903.0K | 631.0K | 506.0K | 2.2M | 1.0M |
| Operating Expenses | |||||
| R&D Expense | 3.9M | 2.2M | 1.8M | 1.6M | 2.8M |
| SG&A Expense | 12.9M | 5.4M | 5.8M | 6.1M | 6.3M |
| General & Admin Expense | 9.0M | 4.7M | 4.3M | 3.6M | 5.2M |
| Selling & Marketing Expense | 2.2M | 718.0K | 1.5M | 2.5M | 1.1M |
| Other Expenses | 202.0K | 1.8M | 202.0K | — | 224.0K |
| Total Operating Expenses | 17.0M | 9.4M | 7.8M | 8.0M | 8.4M |
| Cost and Expenses | 18.2M | 9.6M | 8.6M | 8.7M | 8.7M |
| Operating Income (EBIT) | (16.1M) | (8.7M) | (7.3M) | (5.8M) | (7.4M) |
| Non-Operating | |||||
| Interest Income | 2.8M | 207.0K | 421.0K | — | 1.2M |
| Interest Expense | 8.2M | 11.0K | 30.0K | 9.0K | 36.0K |
| Net Interest Income | (5.5M) | 196.0K | 391.0K | (9.0K) | 6.6M |
| Other Non-Op Income/Expense | (4.0M) | (3.8M) | (170.0K) | (88.0K) | 4.8M |
| Non-Operating Income (excl Interest) | 140.0K | 3.8M | 140.0K | 79.0K | (4.8M) |
| EBT (Pre-Tax Income) | (20.1M) | (12.6M) | (7.5M) | (5.9M) | (2.6M) |
| Income Tax Expense | (24.0K) | — | (14.0K) | 22.0K | 14.0K |
| Bottom Line | |||||
| Net Income | (18.5M) | (12.2M) | (6.3M) | (5.1M) | (2.6M) |
| Earnings from Cont. Ops | (20.0M) | (12.6M) | (7.5M) | (5.9M) | (2.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (18.5M) | (12.2M) | (6.3M) | (5.1M) | (2.6M) |
| Per Share | |||||
| Basic EPS | ($259.42) | ($882.64) | ($9.72) | ($112.95) | ($132.57) |
| Diluted EPS | ($320.62) | ($882.64) | ($9.72) | ($649.35) | ($666.90) |
| Revenue Per Share | $53.25 | $0.06 | $2.02 | $14.60 | $13.86 |
| Shares | |||||
| Basic Shares Outstanding | 40604 | 13.8M | 647219 | 197197 | 97166 |
| Diluted Shares Outstanding | 40604 | 13.8M | 647219 | 226667 | 97778 |
| Profitability Metrics | |||||
| EBITDA | (15.5M) | (12.3M) | (7.0M) | (5.3M) | (2.4M) |
| D&A | 716.0K | 234.0K | 482.0K | 538.0K | 187.0K |
| EBIT | (16.2M) | (12.6M) | (7.5M) | (5.9M) | (2.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025